Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Academic Hospital Journal

Description Of Giving Blood Supplement Tablets To Donor Haemoglobin Levels in PMI Banyumas Regency Febriana, Gita Dwi; Setyaji, Yoki
Academic Hospital Journal Vol 7, No 2 (2025)
Publisher : Rumah Sakit Akademik Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ahj.v7i2.106000

Abstract

Background: Based on data from the Banyumas Regency PMI for August 2023, it is stated that there are 182 requests for blood products every day, but can only fulfil the demand for blood products at 152 blood bags/day, which means that in one day, the Banyumas Regency PMI still lacks 30 blood bags of blood. Everyday. Therefore, this is the background for UDD PMI Kab. Banyumas to provide additional blood supplements of Fe 60 mg and Folic Acid 0.4 mg to donors who failed due to low haemoglobin levels, namely < 12.5 gr/dL. Giving blood supplement tablets is considered to be able to increase haemoglobin levels more quickly than other vitamin supplements because they contain Fe or iron. The purpose of this study was to determine the increase in haemoglobin levels before and after giving blood supplements to blood donors in UDD PMI Banyumas.Method: This quantitative research uses an analytical observational method (Cross-Sectional Study), with a Purposive sampling technique using the Slovin Formula, resulting in 24 samples. Of the 24 prospective blood donors who failed the HB screening selection, they were given treatment with blood supplements of 5 tablets, which were consumed once a day.Result:  The average result of checking the haemoglobin level before administering the blood supplement was 11.48 gr/dL. After taking the blood supplement, the donor checked the haemoglobin level again, and the average haemoglobin level was 12.57 gr/dL. Based on the results of pre- and post-blood supplement examinations, the results showed an average increase in haemoglobin levels of 1.09 gr/dL.Conclusion: Prospective blood donors who consumed blood supplement tablets, namely Fe 12.45 mg and Folic Acid 0.5 mg, 1 tablet per day for 5 days, experienced an average increase in haemoglobin levels of 1.09 gr/dL.
Hemoglobin Levels in PRC Blood Products Before and After Shelf Life Period Ranika Puteri, Orchelanesya Avrilia; Setyaji, Yoki; Setyowatiningsih, Lilik
Academic Hospital Journal Vol 7, No 2 (2025)
Publisher : Rumah Sakit Akademik Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ahj.v7i2.106350

Abstract

Background: PRC is a component found in living creatures, which plays an important role in transporting oxygen and metabolic products to body tissues. PRC transfusion is indicated at Hb levels < 7.0 g/dl, especially in patients with acute anemia. In the transfusion process, before there is a request for blood to be transfused, the blood will be stored in a blood bank. A good blood storage process is needed to maintain the quality of blood products so that they are safe for transfusion. During the storage process, hemoglobin levels in the blood can change. The longer blood is stored, the more red blood cells become fragile and lyse, thereby increasing the concentration of hemoglobin in the blood. This study aims to determine and describe the description of hemoglobin levels in pre- and post-PRC blood products during the shelf life at UDD PMI Rembang Regency.Method: This type of research uses analytical descriptive research and a research design with purposive sampling techniques. The samples used in this study were 30 bags of PRC blood, which met the inclusion and exclusion criteria.Result:  The results of this study showed an increase in hemoglobin levels, with the average pre-storage hemoglobin level being 14.99 g/dl, while the average post-storage hemoglobin level was 17.5 g/dl.Conclusion: In this study, there was an average increase in hemoglobin levels of 2.51 g/dl or 16.74%. This could be caused by temperature, storage time, and anticoagulants.